Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Zhejiang Ludao Technology Co., Ltd.
WARNING LETTER
•Zhejiang Ludao Technology Co., Ltd.•August 18, 2017

Zhejiang Ludao Technology Co., Ltd. – FDA Warning Letter, Aug 18, 2017

Record Details

The FDA inspected Zhejiang Ludao Technology Co., Ltd. from August 14 to 18, 2017, and found significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals, rendering their drug products adulterated under 21 U.S.C. 351(a)(2)(B). Key deficiencies included a failure to ensure complete laboratory records and data integrity (21 CFR 211.194(a)), with evidence of falsified analytical test results and deleted electronic data. The firm also failed to conduct identity testing for drug product components and validate supplier analyses (21 CFR 211.84(d)(1) and (2)). Additionally, the company lacked a proper written stability testing program to determine storage conditions and expiration dates (21 CFR 211.166(a)), with some batches found to be super-potent. The FDA deemed the firm's September 11, 2017, response insufficient, particularly regarding data integrity remediation and component testing. The FDA strongly recommended retaining a qualified consultant to assist with CGMP compliance and data integrity remediation. As a result of these violations, the firm was placed on Import Alert 66-40 on December 28, 2017, and faces potential refusal of admission for its articles into the U.S. and withholding of new drug application approvals. A written response detailing corrective actions is required within 15 working days.

Company
Zhejiang Ludao Technology Co., Ltd.
Inspection date
August 18, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · bf2e2b6b-768c-4157-942a-9275ba0556f0

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.194(a)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.166(a)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Zhejiang Ludao Technology Co., Ltd.
  • 483 - 2017-08-14August 14, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Zhejiang Ludao Technology Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.